Código QR (código de barras bidimensional)

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important common comorbidity in subjects with type 2 diabetes, and liver fibrosis is a factor directly related to its prognosis. Glucagon-like peptide-1 receptor agonists are useful treatment options for MA...

ver descrição completa

Na minha lista:
Principais autores: Hiroya Kitsunai, Yuka Shinozaki, Sho Furusawa, Naoyuki Kitao, Miki Ito, Hiroyoshi Kurihara, Chiho Oba-Yamamoto, Jun Takeuchi, Akinobu Nakamura, Yumi Takiyama, Hiroshi Nomoto
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2025-01-01
coleção:Pharmaceuticals
Assuntos:
GLP-1 receptor agonist
MASLD
type 2 diabetes
semaglutide
observational study
Acesso em linha:https://www.mdpi.com/1424-8247/18/1/129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados